CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

US genetic medicines company Scribe, which is seeking to unlock the potential of CRISPR to transform human health, announced ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...